Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Shanghai Bio-Heart Biological Technology Co., Ltd. Class H ( (HK:2185) ) is now available.
Shanghai Bio-heart Biological Technology Co., Ltd. has announced an unlisted foreign shareholders’ class meeting scheduled for February 13, 2025, to discuss and vote on proposed amendments to the company’s articles of association. This meeting reflects the company’s ongoing efforts to refine its corporate governance structure, potentially impacting its operations and stakeholder relationships.
More about Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
Shanghai Bio-heart Biological Technology Co., Ltd. is a joint stock company based in the People’s Republic of China. Operating within the biotechnology sector, it focuses on developing and delivering biological technologies with a market emphasis in Shanghai’s East Zhangjiang Hi-Tech Park.
YTD Price Performance: -8.54%
Average Trading Volume: 26,992
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$627.8M
See more data about 2185 stock on TipRanks’ Stock Analysis page.